Cargando…

Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy

SIMPLE SUMMARY: Medulloblastoma is a common malignant brain tumor in children. Recent progress includes a paradigm shift from histology-based diagnostics to the molecular and genetic profiling of the tumor for an improved correlation with clinical outcomes. This review aims to introduce the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eibl, Robert H., Schneemann, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952923/ https://www.ncbi.nlm.nih.gov/pubmed/36829544 http://dx.doi.org/10.3390/biology12020267

Ejemplares similares

Liquid biopsy and glioblastoma
por: Eibl, Robert H., et al.
Publicado: (2023)

Liquid Biopsy and Primary Brain Tumors
por: Eibl, Robert H., et al.
Publicado: (2021)

The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
por: Garrido-Navas, M. Carmen, et al.
Publicado: (2020)

Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma
por: Azzollini, Jacopo, et al.
Publicado: (2020)

WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
por: Zhukova, Nataliya, et al.
Publicado: (2014)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
por: Ruiz-Cordero, Roberto, et al.
Publicado: (2020)

Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
por: Dutta, Sayantanee, et al.
Publicado: (2020)

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status
por: Gottlieb, Aline, et al.
Publicado: (2017)

TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
por: George, Binsah, et al.
Publicado: (2021)

Immunological Role of TP53 Somatic Mutation Classification in Human Cancers
por: Fang, Jianfei, et al.
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Molecular variants and mutations in medulloblastoma
por: Schroeder, Kristin, et al.
Publicado: (2014)

MBRS-51. MUTATIONS IN BRPF1 FOUND IN SHH MEDULLOBLASTOMA PREVENT INTERACTION WITH TP53 AND LEADS TO RADIORESISTANCE IN VITRO
por: Vouri, Mikaela, et al.
Publicado: (2020)

The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
por: Brachova, Pavla, et al.
Publicado: (2013)

Overexpressed TP73 induces apoptosis in medulloblastoma
por: Castellino, Robert C, et al.
Publicado: (2007)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)

TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
por: Testa, Ugo, et al.
Publicado: (2023)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
por: Del Re, Marzia, et al.
Publicado: (2022)

Clinical implications of germline mutations in breast cancer: TP53
por: Schon, Katherine, et al.
Publicado: (2017)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery
por: Srinivasan, Visish M., et al.
Publicado: (2016)

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
por: Zhao, Davidson, et al.
Publicado: (2022)

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes
por: Devillier, Raynier, et al.
Publicado: (2015)

MBRS-21. CLINICAL AGGRESSIVENESS OF TP53-WILD TYPE SONIC HEDGEHOG MEDULLOBLASTOMA WITH MYCN AMPLIFICATION
por: Mitani, Yuichi, et al.
Publicado: (2020)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)

Medulloblastoma: molecular pathways and histopathological classification
por: Borowska, Anna, et al.
Publicado: (2016)

TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
por: Ben-Cohen, Gil, et al.
Publicado: (2022)

TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
por: Shin, Dong-Yeop
Publicado: (2023)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

A Comparative Evaluation of Cancer Classification via TP53 Gene Mutations Using Machin Learning
por: Mikhail, Dina Yousif, et al.
Publicado: (2022)

Genomic landscape of TP53-mutated myeloid malignancies
por: Abel, Haley J., et al.
Publicado: (2023)

Genomic landscape of TP53-mutated myeloid malignancies
por: Abel, Haley J., et al.
Publicado: (2023)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion
por: Eisenmann, Eric D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nms8efiqkiq6p2pett3ajmmem8